新华制药(000756.SZ)：上半年净利润2.24亿元 同比下降15.69%

Core Viewpoint - Xinhua Pharmaceutical (000756.SZ) reported a decline in revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 4.639 billion yuan, a year-on-year decrease of 1.98% [1] - The net profit attributable to shareholders was 224 million yuan, down 15.69% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 211 million yuan, a decline of 15.44% year-on-year [1] - Basic earnings per share stood at 0.32 yuan [1]